Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...